IDEXX Laboratories, Inc. - stock earnings
IDXX Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 1, 2024 AfterMarket | 2.81 / 2.72 | - | 964.1 million / 986.6 million | - |
| July 30, 2024 BeforeMarket | - / - | 1.0 billion | - / 1.0 billion | 1.0 billion |
IDXX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 235.6 million USD | 964.1 million USD |
| 2023Q4 | 194.5 million USD | 901.6 million USD |
| 2023Q3 | 212.2 million USD | 915.5 million USD |
| 2023Q2 | 224.2 million USD | 943.6 million USD |
| 2023Q1 | 214.1 million USD | 900.2 million USD |
| 2022Q4 | 172.2 million USD | 828.6 million USD |
| 2022Q3 | 180.9 million USD | 841.7 million USD |
| 2022Q2 | 132.0 million USD | 860.5 million USD |
| 2022Q1 | 194.0 million USD | 836.5 million USD |
| 2021Q4 | 162.8 million USD | 801.1 million USD |
| 2021Q3 | 175.2 million USD | 810.4 million USD |
| 2021Q2 | 202.6 million USD | 826.1 million USD |
| 2021Q1 | 204.3 million USD | 777.7 million USD |
| 2020Q4 | 174.8 million USD | 720.9 million USD |
| 2020Q3 | 146.2 million USD | 721.8 million USD |
| 2020Q2 | 148.9 million USD | 637.6 million USD |
| 2020Q1 | 111.8 million USD | 626.3 million USD |
| 2019Q4 | 90.5 million USD | 605.4 million USD |
| 2019Q3 | 108.8 million USD | 605.3 million USD |
| 2019Q2 | 125.7 million USD | 620.1 million USD |
| 2019Q1 | 102.7 million USD | 576.1 million USD |
| 2018Q4 | 85.6 million USD | 549.4 million USD |
| 2018Q3 | 93.3 million USD | 545.4 million USD |
| 2018Q2 | 108.7 million USD | 580.8 million USD |
| 2018Q1 | 89.5 million USD | 537.7 million USD |
| 2017Q4 | 38.3 million USD | 506.1 million USD |
| 2017Q3 | 70.5 million USD | 492.0 million USD |
| 2017Q2 | 85.4 million USD | 508.9 million USD |
| 2017Q1 | 69.0 million USD | 462.0 million USD |
| 2016Q4 | 52.4 million USD | 443.0 million USD |
| 2016Q3 | 56.5 million USD | 448.3 million USD |
| 2016Q2 | 67.2 million USD | 466.6 million USD |
| 2016Q1 | 46.0 million USD | 417.6 million USD |
| 2015Q4 | 44.3 million USD | 399.7 million USD |
| 2015Q3 | 44.2 million USD | 406.4 million USD |
| 2015Q2 | 56.9 million USD | 413.3 million USD |
| 2015Q1 | 46.6 million USD | 382.5 million USD |
| 2014Q4 | 26.0 million USD | 352.0 million USD |
| 2014Q3 | 52.1 million USD | 383.5 million USD |
| 2014Q2 | 57.2 million USD | 390.1 million USD |
| 2014Q1 | 46.6 million USD | 360.2 million USD |
| 2013Q4 | 43.3 million USD | 354.1 million USD |
| 2013Q3 | 45.7 million USD | 338.3 million USD |
| 2013Q2 | 54.0 million USD | 352.6 million USD |
| 2013Q1 | 44.9 million USD | 332.1 million USD |
| 2012Q4 | 43.4 million USD | 319.5 million USD |
| 2012Q3 | 42.9 million USD | 315.5 million USD |
| 2012Q2 | 51.3 million USD | 335.6 million USD |
| 2012Q1 | 40.7 million USD | 322.7 million USD |
| 2011Q4 | 38.0 million USD | 307.2 million USD |
| 2011Q3 | 38.5 million USD | 301.0 million USD |
| 2011Q2 | 48.7 million USD | 317.9 million USD |
| 2011Q1 | 36.6 million USD | 292.7 million USD |
| 2010Q4 | 36.4 million USD | 283.8 million USD |
| 2010Q3 | 34.7 million USD | 269.6 million USD |
| 2010Q2 | 37.2 million USD | 281.5 million USD |
| 2010Q1 | 33.0 million USD | 268.5 million USD |
| 2009Q4 | 31.0 million USD | 270.3 million USD |
| 2009Q3 | 31.5 million USD | 259.1 million USD |
| 2009Q2 | 33.7 million USD | 265.7 million USD |
| 2009Q1 | 26.1 million USD | 236.5 million USD |
| 2008Q4 | 23.6 million USD | 243.3 million USD |
| 2008Q3 | 25.7 million USD | 251.1 million USD |
| 2008Q2 | 39.4 million USD | 280.6 million USD |
| 2008Q1 | 27.6 million USD | 249.1 million USD |
| 2007Q4 | 25.5 million USD | 245.0 million USD |
| 2007Q3 | 25.8 million USD | 229.4 million USD |
| 2007Q2 | 21.7 million USD | 237.0 million USD |
| 2007Q1 | 21.0 million USD | 211.2 million USD |
| 2006Q4 | 24.7 million USD | 192.2 million USD |
| 2006Q3 | 25.0 million USD | 187.4 million USD |
| 2006Q2 | 25.8 million USD | 191.4 million USD |
| 2006Q1 | 18.3 million USD | 168.2 million USD |
| 2005Q4 | 20.0 million USD | 167.0 million USD |
| 2005Q3 | 20.6 million USD | 158.1 million USD |
| 2005Q2 | 19.9 million USD | 160.6 million USD |
| 2005Q1 | 17.7 million USD | 152.4 million USD |
| 2004Q4 | 16.9 million USD | 144.3 million USD |
| 2004Q3 | 19.7 million USD | 134.1 million USD |
| 2004Q2 | 23.9 million USD | 137.4 million USD |
| 2004Q1 | 17.8 million USD | 133.4 million USD |
| 2003Q4 | 12.4 million USD | 124.8 million USD |
| 2003Q3 | 16.0 million USD | 120.1 million USD |
| 2003Q2 | 16.7 million USD | 121.8 million USD |
| 2003Q1 | 12.1 million USD | 109.2 million USD |
| 2002Q4 | 12.8 million USD | 105.9 million USD |
| 2002Q3 | 12.5 million USD | 104.5 million USD |
| 2002Q2 | 13.0 million USD | 105.7 million USD |
| 2002Q1 | 7.2 million USD | 96.6 million USD |
| 2001Q4 | 9.8 million USD | 95.1 million USD |
| 2001Q3 | 10.2 million USD | 97.5 million USD |
| 2001Q2 | 10.0 million USD | 102.0 million USD |
| 2001Q1 | 7.6 million USD | 91.4 million USD |
| 2000Q4 | 9.8 million USD | 92.6 million USD |
| 2000Q3 | 9.3 million USD | 90.4 million USD |
| 2000Q2 | 9.5 million USD | 93.6 million USD |
| 2000Q1 | 8.0 million USD | 90.9 million USD |
| 1999Q4 | 8.9 million USD | 88.6 million USD |
| 1999Q3 | 8.4 million USD | 86.4 million USD |
| 1999Q2 | 8.0 million USD | 91.5 million USD |
| 1999Q1 | 7.3 million USD | 89.6 million USD |
| 1998Q4 | -30.1 million USD | 82.7 million USD |
| 1998Q3 | 6.0 million USD | 78.5 million USD |
| 1998Q2 | 5.1 million USD | 80.9 million USD |
| 1998Q1 | 3.8 million USD | 77.8 million USD |
| 1997Q4 | -3.1 million USD | 71.8 million USD |
| 1997Q3 | -16.9 million USD | 71.7 million USD |
| 1997Q2 | -2.1 million USD | 58.9 million USD |
| 1997Q1 | 900000 USD | 60.5 million USD |
| 1996Q4 | 9.2 million USD | 74.6 million USD |
| 1996Q3 | 8.6 million USD | 69.8 million USD |
| 1996Q2 | 7.9 million USD | 65.9 million USD |
| 1996Q1 | 7.0 million USD | 57.4 million USD |
| 1995Q4 | 7.1 million USD | 54.2 million USD |
| 1995Q3 | 5.4 million USD | 48.7 million USD |
| 1995Q2 | 4.9 million USD | 46.5 million USD |
| 1995Q1 | 4.0 million USD | 39.2 million USD |
| 1994Q4 | 4.3 million USD | 36.0 million USD |
| 1994Q3 | 3.6 million USD | 31.9 million USD |
| 1994Q2 | 2.6 million USD | 31.1 million USD |
| 1994Q1 | 2.8 million USD | 27.4 million USD |
| 1993Q4 | 3.7 million USD | 26.8 million USD |
| 1993Q3 | 2.6 million USD | 23.8 million USD |
| 1993Q2 | 2.1 million USD | 23.1 million USD |
| 1993Q1 | 1.4 million USD | 19.5 million USD |
| 1992Q4 | 1.7 million USD | 16.4 million USD |
| 1992Q3 | 1.5 million USD | 14.7 million USD |
| 1992Q2 | 1.2 million USD | 14.8 million USD |
| 1992Q1 | 500000 USD | 11.8 million USD |
| 1991Q4 | 1.3 million USD | 9.3 million USD |
| 1991Q3 | 1.0 million USD | 7.5 million USD |
| 1991Q2 | 600000 USD | 7.4 million USD |
| 1991Q1 | ? USD | 6.3 million USD |
IDXX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 845.0 million USD | 3.7 billion USD |
| 2022 | 679.1 million USD | 3.4 billion USD |
| 2021 | 744.8 million USD | 3.2 billion USD |
| 2020 | 581.8 million USD | 2.7 billion USD |
| 2019 | 427.7 million USD | 2.4 billion USD |
| 2018 | 377.0 million USD | 2.2 billion USD |
| 2017 | 263.1 million USD | 2.0 billion USD |
| 2016 | 222.0 million USD | 1.8 billion USD |
| 2015 | 192.1 million USD | 1.6 billion USD |
| 2014 | 181.9 million USD | 1.5 billion USD |
| 2013 | 187.8 million USD | 1.4 billion USD |
| 2012 | 178.3 million USD | 1.3 billion USD |
| 2011 | 161.8 million USD | 1.2 billion USD |
| 2010 | 141.3 million USD | 1.1 billion USD |
| 2009 | 122.2 million USD | 1.0 billion USD |
| 2008 | 116.2 million USD | 1.0 billion USD |
| 2007 | 94.0 million USD | 922.6 million USD |
| 2006 | 93.7 million USD | 739.1 million USD |
| 2005 | 78.3 million USD | 638.1 million USD |
| 2004 | 78.3 million USD | 549.2 million USD |
| 2003 | 57.1 million USD | 476.0 million USD |
| 2002 | 45.4 million USD | 412.7 million USD |
| 2001 | 37.6 million USD | 386.1 million USD |
| 2000 | 36.6 million USD | 367.4 million USD |
| 1999 | 32.6 million USD | 356.2 million USD |
| 1998 | -15.2 million USD | 319.9 million USD |
| 1997 | -21.1 million USD | 263.0 million USD |
| 1996 | 32.6 million USD | 267.7 million USD |
| 1995 | 21.5 million USD | 188.6 million USD |
| 1994 | 13.3 million USD | 126.4 million USD |
| 1993 | 9.7 million USD | 93.1 million USD |
| 1992 | 4.9 million USD | 57.7 million USD |
| 1991 | 3.2 million USD | 30.5 million USD |
IDXX
Price: $480.60
52 week price:
Payout Ratio Range:
Earnings Per Share: 10.04 USD
P/E Ratio: 57.86
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 353885
Ebitda: 120.9 millionMarket Capitalization: 39.3 billion